Dana Farber Cancer Institute Building Background

SESSIONS

  • 1
  • 2
  • 3
  • 4
  • 5

23 23rd

Women’s Cancers and Supportive Care

  • Opening Remarks
    Robert J. Mayer MD – Course Director

Women’s Cancers

Track Leader: Dr. Burstein

  • Molecular Advances and Emerging Treatment Strategies in Ovarian and Endometrial Cancers
    Ursula A. Matulonis MD

  • HER2-Positive and Triple-Negative Breast Cancers: An Evolving Treatment Landscape
    Eric P. Winer MD

  • Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes
    Harold J. Burstein MD, PhD

  • Session Break

Supportive Care

Moderator: Dr. Burstein

  • Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes
    Janet L. Abrahm MD

  • Optimizing Outcomes for Survivors of Cancer
    Ann H. Partridge MD, MPH

  • Panel Discussion

    All Faculty

  • Closing Remarks

24 24th

Hematologic Malignancies

  • Opening Remarks
    Robert J. Mayer MD – Course Director

Hematologic Malignancies

Moderator: Dr. Connors

  • Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach
    Ann S. LaCasce MD, MMSC

  • Myeloid Malignancies: Molecular Markers and Targeted Therapies
    Richard M. Stone MD

  • Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management
    Ayalew Tefferi MD

  • Multiple Myeloma: Current Evidence-Based Management
    Kenneth C. Anderson MD

  • Session Break

  • Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape
    John C. Byrd MD

  • Cancer Associated Venous Thromboembolic Disease: Current Guidance and Clinical Data
    Jean M. Connors MD

  • Panel Discussion

    All Faculty

  • Closing Remarks

6 6th

Gastrointestinal Cancer and Sarcoma

  • Opening Remarks
    Robert J. Mayer MD – Course Director

Sarcoma

Moderator: Dr. Mayer

  • Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma
    George D. Demetri MD

Gastrointestinal Cancers

Moderator: Dr. Mayer

  • Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers
    Peter C. Enzinger MD

  • Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy
    Matthew B. Yurgelun MD

  • Session Break

  • Reducing Risk: Current Clinical Evidence on Lifestyle Management and Chemopreventative Agents in Gastrointestinal Cancer
    Charles S. Fuchs MD, MPH

  • Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment
    Robert J. Mayer MD

  • Panel Discussion

    All Faculty

  • Closing Remarks

7 7th

Head, Neck and Lung Cancers and Melanoma Cancer

  • Opening Remarks
    Robert J. Mayer MD – Course Director

Head, Neck and Lung Cancers

Moderator: Dr. Johnson

  • Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers
    Robert I. Haddad MD

  • NSCLC and SCLC: Molecular Testing and Emerging Treatment Options
    Bruce E. Johnson MD

  • Session Break

Melanoma Cancer

Track Leader: Dr. Johnson

  • Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma
    F. Stephen Hodi MD

  • Panel Discussion

    All Faculty

  • Closing Remarks

13 13th

Genitourinary Cancer

  • Opening Remarks
    Robert J. Mayer MD – Course Director

Moderator: Dr. Johnson

  • COVID and Cancer Treatment
    Amy C. Bessnow MD, MPH

Genitourinary Cancers

Moderator: Dr. Johnson

  • Prostate Cancer: An Evolving Treatment Landscape
    William K. Oh MD

  • Session Break

  • Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice
    Robert Dreicer MD

  • Panel Discussion

    All Faculty

  • Closing Remarks

© 2021 Dana-Farber Cancer Institute's Master Class Virtual Series. All rights reserved.